KRYSTAL STECKEL: Open Payments
NPI 1790026300 · PAHRUMP, NV. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,740 in 92 payments from 11 companies in 2025. Trend: 2023 $384 · 2024 $777 · 2025 $1,740
Food & beverage: $1,740
| Company | Payments | Amount |
|---|---|---|
| Collegium Pharmaceutical, Inc. | 24 | $359 |
| Indivior Inc. | 12 | $334 |
| ABBVIE INC. | 18 | $305 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 15 | $284 |
| PFIZER INC. | 8 | $136 |
| Orexo US, Inc. | 5 | $108 |
| Forte Bio-Pharma LLC | 4 | $89 |
| Azurity Pharmaceuticals, Inc. | 2 | $38 |
| SCILEX PHARMACEUTICALS INC. | 2 | $36 |
| Axsome Therapeutics, Inc. | 1 | $28 |
Products named: SUBLOCADE, RELISTOR, Belbuca, UBRELVY, NURTEC ODT, Nucynta, Zubsolv, QULIPTA.
Industry payments across NV — which companies pay providers there.
